Mar 10, 2021 / 06:50PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
Great. We're live. It's Luke Sergott. There we go. We're live. I'm Luke Sergott. I cover life science tools and diagnostics here at Barclays. My pleasure to have Repligen's CFO, Jon Snodgres with us. I think he's going to go through a couple of slides here, and then we'll dive into some questions. And with that, Jon, go ahead and take it away. Thanks for coming.
Jon K. Snodgres - Repligen Corporation - CFO
All right. Thank you, Luke, and good afternoon, everybody. Appreciate the time this morning. I'll give you a little bit of an overview on what we're up to at Repligen these days and our progress towards becoming a premier bioprocessing company. So before I jump into the slides, I wanted to chat a little bit about some of the important trends we're seeing in the bioprocessing market these days. And these are all about increasing overall efficiency and increasing overall productivity really around the manufacturing processes.
So the first real trend that we're seeing is the
Repligen Corp at Barclays Global Healthcare Conference (Virtual) Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers